Table 1

Baseline features and outcome measures according to CAP bundle delivery

Baseline featuresCAP bundle (n=250)No-CAP bundle (n=1868)OR95% CIp ValueAdjusted OR95% CIp Value
n (%)n (%)
Area first assessed
 Emergency department213 (85.2)1571 (84.1)Reference0.077NA
 Medical admissions unit30 (12.0)275 (14.7)1.240.83 to 1.86
 Other7 (2.8)22 (1.2)2.921.15 to 7.39
Age, median years (IQR)72.6 (62.5–83.8)75.5 (60.6–84.3)NANA0.69NA
Male134 (53.6)953 (51.0)1.110.85 to 1.440.443NA
Low severity (CURB-65, 0–1)104 (41.6)809 (43.3)Reference0.876NA
Moderate severity (CURB-65=2)75 (30.0)513 (27.5)1.140.83 to 1.56
High severity (CURB-65, 3–5)71 (28.4)546 (29.2)1.010.73 to 1.39
Primary outcome measuresCAP bundle (n=196*)No-CAP bundle (n=1552*)
CXR <4 h from admission164 (83.7)1314 (88.8)0.930.62 to 1.390.7170.930.62 to 1.390.708
Oxygen assessment188 (95.9)1473 (94.9)1.260.60 to 2.650.5411.260.60 to 2.650.544
Antibiotic <4 h from admission146 (74.5)1022 (65.9)1.511.08 to 2.120.0161.521.08 to 2.140.016
Guideline-adherent antibiotic choice42/143† (29.4)387/1550† (25.0)1.250.86 to 1.820.247
Guideline-adherent antibiotic route63/143† (44.1)573/1550† (37.0)1.340.95 to 1.900.094
Secondary outcome measureCAP bundle (n=250)No-CAP bundle (n=1862‡)
30-day inpatient mortality22 (8.8)253 (13.6)0.610.39 to 0.970.0350.590.37 to 0.950.03
  • Figures in bold denote p values <0.05.

  • *Data in timing of antibiotic administration, timing of CXR and oxygenation assessment unavailable for 370 adults.

  • †Data regarding antibiotic choice and route of administration unavailable for 425 adults.

  • ‡Data on mortality unavailable for six adults.

  • CAP, community-acquired pneumonia; CXR, chest X-ray; NA, not applicable.